Get startedLog in
    Picture of Predictive Oncology logo

    POAI — Predictive Oncology Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Predictive Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K10-K10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-19.4-25.9-19.7-25.7-14
    Depreciation
    Non-Cash Items8.0813.87.311.20.453
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital1.87-1.21-1.190.867-0.398
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Other Liabilities
    Cash from Operating Activities-8.73-12.3-12.2-12.4-13.2
    Capital Expenditures-0.027-0.361-0.962-0.476-0.302
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-0.5720.193-9.650—
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-0.599-0.167-10.6-0.476-0.302
    Financing Cash Flow Items-0.202-0.222-5.360—
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities9.321350.36.720.149
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-0.0110.52727.5-6.13-13.3